ARTICLE SUMMARY:
Robotics technology is sweeping surgery, bringing with it ever-more sophisticated technologies and high-tech integration. But Swiss robotics company Distalmotion believes that the most important advance may be a step backward.
One of the most electric stories in medtech over the past decade has been the sudden embrace, after a long gestation period, of robotic—or more accurately, robotically-assisted—surgery. Large strategics like Johnson & Johnson, Medtronic plc and virtually every major orthopedics company have launched or acquired—or both—robotic platforms, while an army of small, venture-backed companies have found investor gold in positioning a range of devices as some form of robotics.
